Ligand profile
LMS
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: HT085_RS00030 — leucine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
LMS- PDB
1obh- UniProt (similar protein)
Q72GM3- Target protein
- HT085_RS00030
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 188.7
- −1 ≤ LogP ≤ 5 -2.75
- MW ≤ 500 Da 346.3
- LogP ≤ 5 -2.75
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 188.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COS(=O)(=O)N)O)O)Nc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COS(=O)(=O)N)O)O)N
InChI=1S/C10H14N6O6S/c11-8-5-9(14-2-13-8)16(3-15-5)10-7(18)6(17)4(22-10)1-21-23(12,19)20/h2-4,6-7,10,17-18H,1H2,(H2,11,13,14)(H2,12,19,20)/t4-,6-,7-,10-/m1/s1InChI=1S/C10H14N6O6S/c11-8-5-9(14-2-13-8)16(3-15-5)10-7(18)6(17)4(22-10)1-21-23(12,19)20/h2-4,6-7,10,17-18H,1H2,(H2,11,13,14)(H2,12,19,20)/t4-,6-,7-,10-/m1/s1
GNZLUJQJDPRUTD-KQYNXXCUSA-NGNZLUJQJDPRUTD-KQYNXXCUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00133' 'PF13603
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand LMS →
- PDB RCSB structure 1obh →
- UniProt UniProt Q72GM3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “LMS”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00030.
PDB 20
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 21
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).